You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
眾生藥業(002317.SZ)3000萬元投設控股子公司廣東眾隆創成生物創新公司
格隆匯 12-02 19:54

格隆匯12月2日丨眾生藥業(002317.SZ)公佈,公司緊抓醫藥產業發展機遇充分利區域科技產業創新政策,促進公司整體戰略目標的實現,公司與東莞市石龍鎮工業總公司共同在東莞松山湖高新技術產業開發區投資設立控股子公司,公司以自有資金人民幣3000萬元投資設立控股子公司廣東眾隆創成生物創新有限公司(“眾隆創成”)。

繞公司的“十三五”戰略規劃,推進公司研發戰略實施,公司與東莞市石龍鎮工業總公司共同投資設立子公司,通過發揮雙方優勢資源,充分利用松山湖高新技術產業開發區產業聚集及政策扶持的優勢,共建生物醫藥產業孵化平台,吸引優秀人才和優秀項目,並更好地促進公司研發項目的實施和落地,進一步升公司創新研發能力增強公司綜合競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account